Cwm LLC Has $5.51 Million Stake in Azenta, Inc. (NASDAQ:AZTA)

Cwm LLC decreased its stake in Azenta, Inc. (NASDAQ:AZTA) by 5.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 84,538 shares of the company’s stock after selling 4,804 shares during the quarter. Cwm LLC owned 0.15% of Azenta worth $5,507,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. TFC Financial Management Inc. acquired a new position in Azenta in the third quarter valued at about $25,000. Headlands Technologies LLC acquired a new position in Azenta in the third quarter valued at about $33,000. Neo Ivy Capital Management acquired a new position in Azenta in the third quarter valued at about $73,000. Allworth Financial LP lifted its stake in Azenta by 273.1% in the fourth quarter. Allworth Financial LP now owns 1,634 shares of the company’s stock valued at $106,000 after buying an additional 1,196 shares during the period. Finally, Covestor Ltd increased its holdings in shares of Azenta by 17.5% in the third quarter. Covestor Ltd now owns 1,714 shares of the company’s stock worth $86,000 after acquiring an additional 255 shares in the last quarter. Institutional investors and hedge funds own 99.08% of the company’s stock.

Azenta Stock Performance

NASDAQ:AZTA opened at $52.54 on Wednesday. The company has a market cap of $2.93 billion, a PE ratio of -169.48 and a beta of 1.53. Azenta, Inc. has a 52-week low of $36.01 and a 52-week high of $69.16. The stock has a 50-day simple moving average of $60.15 and a 200 day simple moving average of $59.08.

Azenta (NASDAQ:AZTA) last posted its quarterly earnings data on Wednesday, February 7th. The company reported $0.02 earnings per share (EPS) for the quarter. The business had revenue of $154.32 million during the quarter, compared to the consensus estimate of $151.86 million. Azenta had a positive return on equity of 0.49% and a negative net margin of 2.92%. On average, research analysts predict that Azenta, Inc. will post 0.27 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. Stephens restated an “equal weight” rating and issued a $70.00 price target on shares of Azenta in a report on Thursday, February 8th. Needham & Company LLC restated a “buy” rating and issued a $75.00 price target on shares of Azenta in a report on Monday, April 8th. Evercore ISI lowered their price target on Azenta from $64.00 to $60.00 and set an “in-line” rating for the company in a report on Thursday, April 4th. B. Riley increased their price target on Azenta from $61.00 to $79.00 and gave the stock a “buy” rating in a report on Thursday, February 1st. Finally, Jefferies Financial Group started coverage on Azenta in a report on Thursday, April 4th. They issued a “hold” rating and a $64.00 price target for the company. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $69.60.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.